Genpact (NYSE: G) will report its financial results for the second quarter ended June 30, 2025 after the close of the U.S. financial markets on Thursday, August 7, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. https://mma.prnewswire.com/media/2490373/Genpact_Logo.jpg Participants are encouraged to register […]
Kennametal Inc. (NYSE: KMT) today announced it has been named to TIME's list of America's Best Midsize Companies 2025, a prestigious recognition presented by TIME and Statista Inc., the leading statistics and industry ranking provider. The award highlights Kennametal's continued leadership in employee satisfaction, sustainability transparency and other relevant criteria. https://mma.prnewswire.com/media/2129550/Kennametal_Logo.jpg “We are honored to
Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2025 following the close of market on Thursday, July 31, 2025. On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) JacobThaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call
Gen Digital Inc. (NASDAQ: GEN) today announced that its fiscal 2026 first quarter financial results will be released Thursday, August 7, 2025, after market close. Following the press release, Gen management will host a conference call and webcast at 2 p.m. PT / 5 p.m. ET. https://mma.prnewswire.com/media/1939092/Gen_Logo.jpg Fiscal 2026 Q1 Earnings Call August 7, 2025
(NasdaqGM:MAZE), SOUTH SAN FRANCISCO, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, today announced that company management will participate in fireside chats during two upcoming investor conferences in July: H.C. Wainwright 4th Annual Kidney
(NasdaqGM:APPN), MCLEAN, Va., July 10, 2025 (GLOBE NEWSWIRE) — Appian (NASDAQ: APPN) today announced that it will release financial results for the second quarter ended June 30, 2025 before the U.S. financial markets open on Thursday, August 7, 2025. The company will host a conference call and live webcast to review its financial results and
(NASDAQ:JUNS), Nasdaq compliance follows positive upward trend in Company's Stock Price Jupiter, Florida, July 10, 2025 (GLOBE NEWSWIRE) — Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL(TM), a patented resveratrol-based platform, today announced it has regained compliance with the Nasdaq Stock Market (“Nasdaq”) continued listing standard for minimum
(NASDAQ:NDAQ), NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of June 30, 2025, short interest in 3,257 Nasdaq Global MarketSM securities totaled 14,138,758,851 shares compared with 13,689,191,607 shares in 3,207 Global Market issues reported for the prior settlement date of June 13, 2025. The mid-June short interest represents
(NASDAQ:ITRI), LIBERTY LAKE, Wash., July 10, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced today that it will release financial results for the quarter ended June 30, 2025 before market opens on Thursday, July 31, 2025. The company's press release
(NASDAQ:ALHC), ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will